1057652-84-2

Basic information

• Product Name: Methyl3-chloro-4-Methyl-5-nitrobenzoate
• Synonyms: Methyl3-chloro-4-Methyl-5-nitrobenzoate;Benzoic acid, 3-chloro-4-Methyl-5-nitro-, Methyl ester
• CAS NO: 1057652-84-2
• Molecular Formula: C₉H₈ClNO₄
• Molecular Weight: 229.61712
• Mol File: 1057652-84-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl3-chloro-4-Methyl-5-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl3-chloro-4-Methyl-5-nitrobenzoate(1057652-84-2)
• EPA Substance Registry System: Methyl3-chloro-4-Methyl-5-nitrobenzoate(1057652-84-2)

Safety Data

• Hazardous Substances Data: 1057652-84-2(Hazardous Substances Data)

Usage

General Description

Methyl 3-chloro-4-methyl-5-nitrobenzoate is a chemical compound with the molecular formula C9H8ClNO4. It is a derivative of benzoic acid and contains a methyl group, a chloro group, and a nitro group attached to a benzene ring. Methyl3-chloro-4-Methyl-5-nitrobenzoate is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various drugs and pharmaceuticals. It is also utilized as a chemical intermediate in the production of other organic compounds. Methyl 3-chloro-4-methyl-5-nitrobenzoate is considered a hazardous substance and should be handled with care and used in a controlled laboratory setting.

Upstream product

• 72922-60-2 methyl 3-amino-4-methyl-5-nitrobenzoate 
• 16533-71-4 3,5-dinitro-p-toluic acid 
• 49592-71-4 methyl 4-methyl-3,5-dinitrobenzoate 

Downstream Products

• 1057652-85-3 methyl 4-bromomethyl-3-chloro-5-nitro-benzoate 
• 1070886-76-8 C₂₀H₂₆ClNO₈ 
• 1070886-77-9 C₁₁H₁₀ClNO₆ 
• 1070886-78-0 C₁₇H₁₄Cl₂N₂O₅ 
• 1070886-79-1 C₁₇H₁₆Cl₂N₂O₃ 
• 1070885-59-4 C₂₇H₂₈Cl₂N₄O₄S 
• 1070886-45-1 C₁₂H₁₀ClNO₈ 
• 1070886-33-7 C₂₆H₂₆Cl₂N₄O₄S 
• 1092307-46-4 methyl 3-amino-5-chloro-4-methylbenzoate 

Relevant articles and documents

Aryl imidazole derivative and application thereof

The invention relates to an aryl imidazole derivative and application thereof. The aryl imidazole derivative is a compound shown as a formula (I) in the description or pharmaceutically acceptable salt thereof. The invention also discloses application of the aryl imidazole derivative in preparation of drugs for treating cancers. The invention further discloses application of the aryl imidazole derivative in preparation of drugs for treating diseases caused by EGFR mutation.

Orally active zwitterionic factor Xa inhibitors with long duration of action

We have optimized 2-aminomethylphenylamine derivative as a factor Xa inhibitor. Several polar functional groups were introduced in the central phenyl ring, and we focused on zwitter ionic compound showing continuous inhibitory activity in oral administrat